Immune begins Phase II CMB305 trial to treat soft tissue sarcoma
Immune Design has started a Phase II trial of CMB305, a combination cancer immunotherapy for soft tissue sarcoma.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Immunotherapy | Pharmaceuticals | Sarcomas | Soft Tissue Sarcoma